Creating biodegradable-polymer drug-eluting stents: Shortening the duration of polymer and dual antiplatelet therapy while lengthening the follow-up

Authors

  • Ahmed Abdel-Latif MD, MSPH,

    1. Division of Cardiovascular MedicineGill Heart Institute and University of Kentucky Lexington, Kentucky
    Search for more papers by this author
  • David J. Moliterno MD

    Corresponding author
    1. Division of Cardiovascular MedicineGill Heart Institute and University of Kentucky Lexington, Kentucky
    • Department of Cardiovascular Medicine, University of Kentucky, 900 S. Limestone Avenue, 317 Wethington Building, Lexington, KY 40536-0200
    Search for more papers by this author
    • Tel.: +859-323-5843. Fax: +859-257-3537


  • Conflict of interest: Dr. Moliterno has received past honoraria for serving on data-safety monitoring committees for stent manufacturers, including Boston-Scientific and Abbott.

No abstract is available for this article.

Ancillary